These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37263738)

  • 1. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).
    Deslee G; Fabry-Vendrand C; Poccardi N; Thabut G; Eteve Pitsaer C; Coriat A; Renaudat C; Maguire A; Pinto T
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37263738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
    Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
    Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to single inhaler triple therapy and digital inhalers in Chronic Obstructive Pulmonary Disease: a literature review and protocol for a randomized controlled trial (TRICOLON study).
    Cuperus LJA; van der Palen J; Aldenkamp A; van Huisstede A; Bischoff EWMA; van Boven JFM; Brijker F; Dik S; van Excel JAJM; Goosens M; van Hal PTW; Kuijvenhoven JC; Kunz LIZ; Vasbinder EC; Kerstjens HAM; In 't Veen JCCM;
    BMC Pulm Med; 2024 Jul; 24(1):317. PubMed ID: 38965541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States.
    Bogart M; Bengtson LGS; Johnson MG; Bunner SH; Gronroos NN; DiRocco KK
    Int J Chron Obstruct Pulmon Dis; 2024; 19():97-110. PubMed ID: 38226396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England.
    Rothnie KJ; Joksaite S; Sansbury LB; Compton C; Di Boscio V; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1455-1466. PubMed ID: 35769225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
    Lee CH; Kim MS; Yeo SH; Rhee CK; Park HW; Yang BR; Lee J; Cho EY; Xu X; Navarro Rojas AA; Shantakumar S; Milea D; Choi NK
    Respir Res; 2022 Sep; 23(1):231. PubMed ID: 36064539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler
    Lin L; Liu C; Cheng W; Song Q; Zeng Y; Li X; Deng D; Liu D; Chen Y; Cai S; Chen P
    Front Pharmacol; 2023; 14():1147985. PubMed ID: 37025493
    [No Abstract]   [Full Text] [Related]  

  • 9. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand.
    Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice.
    Sansbury LB; Bains C; Lipson DA; Ismaila AS; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1255-1264. PubMed ID: 33986594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
    Mannino D; Bogart M; Wu B; Germain G; Laliberté F; MacKnight SD; Jung Y; Stiegler M; Duh MS
    Respir Med; 2022 Jun; 197():106807. PubMed ID: 35429764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
    Sansbury LB; Wood RP; Anley GA; Nam Y; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2795-2808. PubMed ID: 34675504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings.
    Cazzola M; Calzetta L; Rinaldi B; De Novellis V; Rogliani P; Matera MG
    Expert Rev Respir Med; 2022; 16(11-12):1205-1212. PubMed ID: 36629483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management.
    Busse WW; Abbott CB; Germain G; Laliberté F; MacKnight SD; Jung Y; Duh MS; Averell CM
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2904-2913.e6. PubMed ID: 35752431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region.
    Resta E; Scioscia G; Lacedonia D; Quarato CMI; Panza F; Resta O; Lepore G; Buonamico E; Di Lecce V; Carpagnano GE; Barbaro MPF; Rossi N
    BMC Health Serv Res; 2022 Oct; 22(1):1283. PubMed ID: 36284319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
    Suissa S; Dell'Aniello S; Ernst P
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in Asthma.
    Oppenheimer J; Bogart M; Bengtson LGS; White J; Sundquist K; Lima R; Averell C
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):485-494.e5. PubMed ID: 34626859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
    Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.
    Miravitlles M; Marín A; Huerta A; Carcedo D; Villacampa A; Puig-Junoy J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1643-1654. PubMed ID: 32764910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.